{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:35:26Z","timestamp":1757540126449},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10552-013-0279-9","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T10:14:27Z","timestamp":1377771267000},"page":"2027-2034","source":"Crossref","is-referenced-by-count":9,"title":["Non-steroidal anti-inflammatory drug use and brain tumour risk: a case\u2013control study within the Clinical Practice Research Datalink"],"prefix":"10.1007","volume":"24","author":[{"given":"F. J.","family":"Bannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"O\u2019Rorke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. T.","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. R.","family":"Cardwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"279_CR1","unstructured":"Cancer Research UK (2012) Brain and other CNS tumour statistics. http:\/\/info.cancerresearchuk.org\/cancerstats\/types\/brain\/uk-brain-and-cns-tumour-statistics"},{"key":"279_CR2","doi-asserted-by":"crossref","first-page":"ii12","DOI":"10.1136\/jnnp.2004.040741","volume":"75","author":"PA McKinney","year":"2004","unstructured":"McKinney PA (2004) Brain tumours: incidence, survival and aetiology. J Neurol Neurosurg Psychiatry 75:ii12\u2013ii17. doi: 10.1136\/jnnp.2004.040741","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"279_CR3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpneuro0289","volume":"2","author":"JA Schwartzbaum","year":"2006","unstructured":"Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Nuerol 2:494\u2013503. doi: 10.1038\/ncpneuro0289","journal-title":"Nat Clin Pract Nuerol"},{"key":"279_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/neuonc\/4.4.278","volume":"4","author":"M Wrensch","year":"2002","unstructured":"Wrensch M, Minn Y, Chew T et al (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278\u2013299. doi: 10.1093\/neuonc\/4.4.278","journal-title":"Neuro Oncol"},{"key":"279_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314. doi: 10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"key":"279_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3171\/jns.1997.86.1.0113","volume":"86","author":"DW Hsu","year":"1997","unstructured":"Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113\u2013120","journal-title":"J Neurosurg"},{"key":"279_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2007.14.2133","volume":"26","author":"S Blitshteyn","year":"2008","unstructured":"Blitshteyn S, Crook JE, Jaeckle KA (2008) Is there an association between meningioma and hormone replacement therapy. J Clin Oncol 26:279\u2013282","journal-title":"J Clin Oncol"},{"key":"279_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/13697137.2010.533615","volume":"14","author":"A Pines","year":"2011","unstructured":"Pines A (2011) Hormone therapy and brain tumours. Climacteric 14:215\u2013216","journal-title":"Climacteric"},{"key":"279_CR9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/jnci\/djm170","volume":"99","author":"E Linos","year":"2007","unstructured":"Linos E, Raine T, Alonso A, Michaud D (2007) Atopy and risk of brain tumours: a meta-analysis. J Natl Cancer Inst 99:1544\u20131550","journal-title":"J Natl Cancer Inst"},{"key":"279_CR10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3171\/jns.2005.103.3.0508","volume":"103","author":"BT Ragel","year":"2005","unstructured":"Ragel BT, Jensen RL, Gillespie DL et al (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103:508\u2013517","journal-title":"J Neurosurg"},{"key":"279_CR11","doi-asserted-by":"crossref","unstructured":"Kato Y, Nishihara H, Mohri H, et al. (2012) Clinicopathological evaluation of cyclooxygenase-2-expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma. Brain Tumor Pathol (epub ahead of print)","DOI":"10.1007\/s10014-012-0127-8"},{"key":"279_CR12","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/FOC-07\/10\/E7","volume":"23","author":"BT Ragel","year":"2007","unstructured":"Ragel BT, Jensen RL, Couldwell WT (2007) Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors. Neurosurg Focus 23:E7","journal-title":"Neurosurg Focus"},{"key":"279_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.pai.0000201807.58801.fc","volume":"15","author":"AM Buccoliero","year":"2007","unstructured":"Buccoliero AM, Castiglione F, Rossi Deggli\u2019Innocenti D et al (2007) Cyclooxygenase-2 (COX-2) overexpression in meningioma: real time PCR and immunohistochemistry. Appl Immunohistochem Mol Morphol 15:187\u2013192","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"279_CR14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/07357900701508280","volume":"25","author":"S Pistolesi","year":"2007","unstructured":"Pistolesi S, Boldrini L, Gisfredi S et al (2007) Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas. Cancer Invest 25:555\u2013562","journal-title":"Cancer Invest"},{"key":"279_CR15","first-page":"27","volume":"21","author":"M El-Sayed","year":"2011","unstructured":"El-Sayed M, Taha MM (2011) Immunohistochemical expression of cyclooyxgenase-2 in astrocytoma: correlation with angiogenesis, tumour progression and survival. Turk Neurosurg 21:27\u201335","journal-title":"Turk Neurosurg"},{"key":"279_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10735-009-9250-1","volume":"40","author":"SG Temel","year":"2009","unstructured":"Temel SG, Kahveci Z (2009) Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma. J Mol Histol 40:369\u2013377","journal-title":"J Mol Histol"},{"key":"279_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-011-0662-x","volume":"106","author":"GR Sareddy","year":"2011","unstructured":"Sareddy GR, Geeviman K, Ramulu C, Babu PP (2011) The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-\u03baB pathway. J Neurooncol 106:99\u2013109","journal-title":"J Neurooncol"},{"key":"279_CR18","first-page":"4926","volume":"60","author":"T Joki","year":"2000","unstructured":"Joki T, Heese O, Nikas DC et al (2000) Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-II inhibitor, NS-398. Cancer Res 60:4926\u20134931","journal-title":"Cancer Res"},{"key":"279_CR19","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1038\/sj.onc.1204907","volume":"20","author":"JG King","year":"2001","unstructured":"King JG, Khalili K (2001) Inhibition of human brain tumour cell growth by the anti-inflammatory drug, flurbiprofen. Oncogene 20:6864\u20136870","journal-title":"Oncogene"},{"key":"279_CR20","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1158\/0008-5472.CAN-07-5675","volume":"68","author":"N Wakimoto","year":"2008","unstructured":"Wakimoto N, Wolf I, Yin D et al (2008) Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. Cancer Res 68:6978\u20136986","journal-title":"Cancer Res"},{"key":"279_CR21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1535-7163.MCT-10-0415","volume":"10","author":"K Xu","year":"2011","unstructured":"Xu K, Gao H, Shu HK (2011) Celecoxib can induce vascular endothelial growth factor expression and tumour angiogenesis. Mol Cancer Ther 10:138\u2013147","journal-title":"Mol Cancer Ther"},{"key":"279_CR22","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","volume":"71","author":"M Fujita","year":"2011","unstructured":"Fujita M, Kohanbash G, Fellows-Mayle W et al (2011) COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 71:2664\u20132674. doi: 10.1158\/0008-5472.CAN-10-3055","journal-title":"Cancer Res"},{"key":"279_CR23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cncr.22441","volume":"109","author":"BT Ragel","year":"2007","unstructured":"Ragel BT, Jensen RL, Gillespie DL et al (2007) Celecoxib inhibits meningioma tumour growth in a mouse xenograft model. Cancer 109:588\u2013597","journal-title":"Cancer"},{"key":"279_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.neo.7900226","volume":"4","author":"DH Hwang","year":"2002","unstructured":"Hwang DH, Fung V, Dannenberg AJ (2002) National Cancer Institute workshop on chemopreventative properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and independent mechanisms. Neoplasia 4:91\u201397","journal-title":"Neoplasia"},{"key":"279_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","volume":"6","author":"CM Ulrich","year":"2006","unstructured":"Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6:130\u2013140. doi: 10.1038\/nrc1801","journal-title":"Nat Rev Cancer"},{"key":"279_CR26","first-page":"6","volume":"57","author":"N Nathoo","year":"2004","unstructured":"Nathoo N, Barnett GH, Golubic M (2004) The eicosanoid cascade: possible role of gliomas and meningiomas. Mol Pathol 57:6\u201313","journal-title":"Mol Pathol"},{"key":"279_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1607-551X(09)70076-2","volume":"20","author":"S-L Hwang","year":"2004","unstructured":"Hwang S-L, Lee K-S, Lin C-L et al (2004) Effect of aspirin and indomethacin on prostaglandin E2 synthesis in C6 glioma cells. Kaohsiung J Med Sci 20:1\u20132","journal-title":"Kaohsiung J Med Sci"},{"key":"279_CR28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2009.07.022","volume":"387","author":"SR Kim","year":"2009","unstructured":"Kim SR, Bae MK, Kim JY et al (2009) Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun 387:342\u2013347. doi: 10.1016\/j.bbrc.2009.07.022","journal-title":"Biochem Biophys Res Commun"},{"key":"279_CR29","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1158\/1940-6207.CAPR-11-0274","volume":"4","author":"SE Daugherty","year":"2011","unstructured":"Daugherty SE, Moore SC, Pfeiffer RM et al (2011) Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort. Cancer Prev Res 4:2027\u20132034. doi: 10.1158\/1940-6207.CAPR-11-0274","journal-title":"Cancer Prev Res"},{"key":"279_CR30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjc.6600760","volume":"88","author":"S Friis","year":"2003","unstructured":"Friis S, Sorensen HT, McLaughlin JK et al (2003) A population-based cohort study of the risk of colorectal cad other cancers among users of low-dose aspirin. Br J Cancer 88:664\u2013668","journal-title":"Br J Cancer"},{"key":"279_CR31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/bjc.2013.87","volume":"108","author":"D Gaist","year":"2013","unstructured":"Gaist D, Garc\u00eda-Rodr\u00edguez LA, S\u00f8rensen HT et al (2013) Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study. Br J Cancer 108:1189\u20131194","journal-title":"Br J Cancer"},{"key":"279_CR32","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/ijc.25883","volume":"129","author":"ME Scheurer","year":"2011","unstructured":"Scheurer ME, Amirian ES, Davlin SL et al (2011) Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies. Int J Cancer 129:2290\u20132296. doi: 10.1002\/ijc.25883","journal-title":"Int J Cancer"},{"key":"279_CR33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/aje\/kwh153","volume":"159","author":"NR Sivak-Sears","year":"2004","unstructured":"Sivak-Sears NR, Schwartzbaum JA, Miike R et al (2004) Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme. Am J Epidemiol 159:1131\u20131139. doi: 10.1093\/aje\/kwh153","journal-title":"Am J Epidemiol"},{"key":"279_CR34","doi-asserted-by":"crossref","first-page":"E1031","DOI":"10.1002\/ijc.27536","volume":"131","author":"J Ferris","year":"2012","unstructured":"Ferris J, McCoy L, Neugut AI et al (2012) HMG CoA reductase inhibitors, NSAIDs and risk of glioma. Int J Cancer 131:E1031\u2013E1037","journal-title":"Int J Cancer"},{"key":"279_CR35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1468-1331.2010.03187.x","volume":"18","author":"C Chen","year":"2011","unstructured":"Chen C, Xu T, Chen J et al (2011) Allergy and risk of glioma: a meta-analysis. Eur J Neurol 18:387\u2013395. doi: 10.1111\/j.1468-1331.2010.03187.x","journal-title":"Eur J Neurol"},{"key":"279_CR36","doi-asserted-by":"crossref","unstructured":"Fan ZX, Shen J, Wu YY, Yu H, Zhu Y, Zhan RY (2013) Hormone replacement therapy and risk of meningioma in women: a meta-analysis. Cancer Causes Control 24(8):1517\u20131525","DOI":"10.1007\/s10552-013-0228-7"},{"key":"279_CR37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women\u2019s Health Study: a randomized controlled trial. JAMA 294:47\u201355","journal-title":"JAMA"},{"key":"279_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF et al (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377:31\u201341","journal-title":"Lancet"},{"key":"279_CR39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pds.3374","volume":"22","author":"R Boggon","year":"2013","unstructured":"Boggon R, van Staa TP, Chapman M et al (2013) Cancer recording and mortality in the general practice research database and linked cancer registries. Pharmacoepidemiol Drug Saf 22:168\u2013175","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"279_CR40","unstructured":"Proprietary Association of Great Britain (2013) Annual review 2012. http:\/\/www.pagb.co.uk\/publications\/annualreview.html"},{"key":"279_CR41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1592\/phco.22.5.303.33189","volume":"22","author":"CR Meier","year":"2002","unstructured":"Meier CR, Schmitz S, Jick H (2002) Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast or colon cancer. Pharmacotherapy 22:303\u2013309","journal-title":"Pharmacotherapy"},{"key":"279_CR42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/pds.1454","volume":"16","author":"UM Yood","year":"2007","unstructured":"Yood UM, Campbell UB, Rothman KJ et al (2007) Using prescription claims data for drugs available over-the-counter (OTC) y. Pharmacoepidemiol Drug Saf 16:961\u2013968. doi: 10.1002\/pds","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"279_CR43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/pds.1599","volume":"17","author":"Y Yang","year":"2008","unstructured":"Yang Y, Pharmd SH, Propert K et al (2008) Chronic statin therapy and the risk of colorectal cancer y. Pharmacoepidemiol Drug Saf 17:869\u2013876. doi: 10.1002\/pds","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"279_CR44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.12968\/bjha.2011.5.9.433","volume":"5","author":"M Perry","year":"2011","unstructured":"Perry M (2011) Medication, polypharmacy and compliance in older people. Br J Health Care Assist 5:433\u2013435","journal-title":"Br J Health Care Assist"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-013-0279-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0279-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T15:31:53Z","timestamp":1563809513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-013-0279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1007\/s10552-013-0279-9","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}